Concordance of skin test reactivity between indoor inhalant allergens among children with allergic respiratory disease

por Kulalert, Prapasri, Sritipsukho, Paskorn, Nanthapisal, Sira, Poachanukoon, Orapan
Publicado 2021

Paediatric Behçet’s disease: a UK tertiary centre experience

por Nanthapisal, Sira, Klein, Nigel J, Ambrose, Nicola, Eleftheriou, Despina, Brogan, Paul A.
Publicado 2016

Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching ana...

por Kulalert, Prapasri, Phinyo, Phichayut, Patumanond, Jayanton, Smathakanee, Chutima, Chuenjit, Wantida, Nanthapisal, Sira
Publicado 2020

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation

por Kulalert, Prapasri, Phinyo, Phichayut, Patumanond, Jayanton, Smathakanee, Chutima, Chuenjit, Wantida, Nanthapisal, Sira
Publicado 2020

Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol

por Pitrez, Paulo Marcio, Nanthapisal, Sira, Castro, Ana Paula Beltran Moschione, Teli, Chirag, P G, Abhijith
Publicado 2023

Diagnostic accuracy of atopy patch test in children with cow’s milk allergy

por Kulalert, Prapasri, Pongcharoen, Padcha, Sritipsukho, Paskorn, Intraakhao, Sukkrawan, Piriyanon, Punnapat, Thaweekul, Patcharapa, Nanthapisal, Sira, Poachanukoon, Orapan
Publicado 2023

Minimum number and types of allergens for a skin prick test panel in Thai children with allergic respiratory diseases

por Kulalert, Prapasri, Poachanukoon, Orapan, Nanthapisal, Sira, Sritipsukho, Paskorn, Thanborisutkul, Karnsinee, Termworasin, Pasistha, Kornsawai, Rungrawee, Punyashthira, Patcharaporn
Publicado 2022

Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosis

por Murphy, Claire, Nanthapisal, Sira, Gilmour, Kimberly, Laurent, Sue, D'Arco, Felice, Hemingway, Cheryl, Brogan, Paul, Eleftheriou, Despina
Publicado 2016

CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes

por Laisuan, Wannada, Wongsa, Chamard, Chiewchalermsri, Chirawat, Thongngarm, Torpong, Rerkpattanapipat, Ticha, Iamrahong, Pansa, Ruangwattanachok, Chulapha, Nanthapisal, Sira, Sompornrattanaphan, Mongkhon
Publicado 2021

The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study

por Sathitakorn, Ornnicha, Jantarathaneewat, Kittiya, Weber, David J., Warren, David K., Nanthapisal, Sira, Rutjanawech, Sasinuch, Apisarnthanarak, Piyaporn, Apisarnthanarak, Anucha
Publicado 2022

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I

por Nanthapisal, Sira, Eleftheriou, Despina, Gilmour, Kimberly, Leone, Valentina, Ramnath, Radhika, Omoyinmi, Ebun, Hong, Ying, Klein, Nigel, Brogan, Paul A.
Publicado 2018

Autoinflammation due to homozygous S208 MEFV mutation

por Hong, Ying, Standing, Ariane S I, Nanthapisal, Sira, Sebire, Neil, Jolles, Stephen, Omoyinmi, Ebun, Verstegen, Ruud HJ, Brogan, Paul A, Eleftheriou, Despina
Publicado 2019

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222

por Nantanee, Rapisa, Jantarabenjakul, Watsamon, Jaru-Ampornpan, Peera, Sodsai, Pimpayao, Himananto, Orawan, Athipunjapong, Jitthiwa, Sophonphan, Jiratchaya, Nanthapisal, Sira, Hirankarn, Nattiya, Puthanakit, Thanyawee
Publicado 2022

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine

por Tangsathapornpong, Auchara, Nanthapisal, Sira, Pontan, Kanassanan, Bunjoungmanee, Pornumpa, Neamkul, Yamonbhorn, Boonyarangkul, Arthit, Wanpen, Supattra, Fukpho, Waraphon, Jitpokasem, Sumana, Tharabenjasin, Phuntila, Jaru-Ampornpan, Peera
Publicado 2023

Secondary C1q Deficiency in Activated PI3Kδ Syndrome Type 2

por Hong, Ying, Nanthapisal, Sira, Omoyinmi, Ebun, Olbrich, Peter, Neth, Olaf, Speckmann, Carsten, Lucena, Jose Manuel, Gilmour, Kimberly, Worth, Austen, Klein, Nigel, Eleftheriou, Despina, Brogan, Paul
Publicado 2019

A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines

por Nanthapisal, Sira, Puthanakit, Thanyawee, Jaru-Ampornpan, Peera, Nantanee, Rapisa, Sodsai, Pimpayao, Himananto, Orawan, Sophonphan, Jiratchaya, Suchartlikitwong, Pintip, Hiransuthikul, Narin, Angkasekwinai, Pornpimon, Tangsathapornpong, Auchara, Hirankarn, Nattiya
Publicado 2022

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants

por Niyomnaitham, Suvimol, Jongkaewwattana, Anan, Meesing, Atibordee, Pinpathomrat, Nawamin, Nanthapisal, Sira, Hirankarn, Nattiya, Siwamogsatham, Sarawut, Kirdlarp, Suppachok, Chaiwarith, Romanee, Lawpoolsri, Saranath, Phanthanawiboon, Supranee, Thitithanyanont, Arunee, Hansasuta, Pokrath, Chaiyaroj, Sansanee, Pitisuttithum, Punnee
Publicado 2023

Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study

por Sritipsukho, Paskorn, Khawcharoenporn, Thana, Siribumrungwong, Boonying, Damronglerd, Pansachee, Suwantarat, Nuntra, Satdhabudha, Araya, Chaiyakulsil, Chanapai, Sinlapamongkolkul, Phakatip, Tangsathapornpong, Auchara, Bunjoungmanee, Pornumpa, Nanthapisal, Sira, Tanprasertkul, Chamnan, Sritipsukho, Naiyana, Mingmalairak, Chatchai, Apisarnthanarak, Anucha, Tantiyavarong, Pichaya
Publicado 2022

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

por Sritipsukho, Paskorn, Khawcharoenporn, Thana, Siribumrungwong, Boonying, Damronglerd, Pansachee, Suwantarat, Nuntra, Satdhabudha, Araya, Chaiyakulsil, Chanapai, Sinlapamongkolkul, Phakatip, Tangsathapornpong, Auchara, Bunjoungmanee, Pornumpa, Nanthapisal, Sira, Tanprasertkul, Chamnan, Sritipsukho, Naiyana, Mingmalairak, Chatchai, Apisarnthanarak, Anucha, Tantiyavarong, Pichaya
Publicado 2023

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial

por Muangnoicharoen, Sant, Wiangcharoen, Rakpong, Nanthapisal, Sira, Kamolratakul, Supitcha, Lawpoolsri, Saranath, Jongkaewwattana, Anan, Thitithanyanont, Arunee, Luvira, Viravarn, Chinwangso, Pailinrut, Thanthamnu, Narumon, Chantratita, Narisara, Lim, Jacqueline Kyungah, Anh Wartel, T., Excler, Jean-Louis, Ryser, Martin F., Leong, Chloe, Mak, Tippi K., Pitisuttithum, Punnee
Publicado 2023